Daejeon

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• High blood pressure1 trial
• Neuromyelitis optica (NMOSD)1 trial

Phase

• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• Alexion Pharmaceuticals, Inc.1 trial
• Alnylam Pharmaceuticals1 trial

Running trials

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

  NCT05966467· Alexion Pharmaceuticals, Inc.· Source

  Contact: Eun Hee Sohn

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting